Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management

Johnson, F., Hauber, A., Ozdemir, S., Hass, S., Siegel, C., & Sands, B. (2009). Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management. International Journal of Medical and Biological Frontiers, 15(5/6), 457-66.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments
Article

The importance of quality data to track global progress in addressing stillbirths and neonatal mortality
Article

Pre-natal exposure to NO2 and PM2.5 and newborn lung function